BRIGHT MINDS BIOSCIENCES INC. Income Tax Expense Continuing Operations
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Income Tax Expense Continuing Operations of CAD 0 for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2024-12-31
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2024-09-30 | 0.00 CAD 20-F · filed 2024-12-31 |
| 2023-09-30 | 0.00 CAD 20-F · filed 2024-12-31 |
| 2022-09-30 | 0.00 CAD 20-F · filed 2024-12-31 |
| 2021-09-30 | 0.00 CAD 20-F · filed 2023-12-29 |
| 2020-09-30 | 0.00 CAD 20-F · filed 2022-12-29 |
| 2019-09-30 | 0.00 CAD 20-F/A · filed 2022-01-18 |